Cerus Corporation
CERS
#7707
Rank
โ‚น44.83 B
Marketcap
โ‚น222.48
Share price
0.88%
Change (1 day)
56.66%
Change (1 year)

Revenue for Cerus Corporation (CERS)

Revenue in 2026 (TTM): โ‚น20.33 Billion

According to Cerus Corporation's latest financial reports the company's current revenue (TTM ) is โ‚น21.43 Billion. In 2025 the company made a revenue of โ‚น18.50 Billion an increase over the revenue in the year 2024 that were of โ‚น15.46 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cerus Corporation from 1997 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น20.33 B9.89%
2025 โ‚น18.50 B19.66%
2024 โ‚น15.46 B18.8%
2023 โ‚น13.01 B-2.92%
2022 โ‚น13.40 B37.67%
2021 โ‚น9.73 B44.89%
2020 โ‚น6.72 B26.28%
2019 โ‚น5.32 B24.99%
2018 โ‚น4.25 B53.09%
2017 โ‚น2.78 B10.1%
2016 โ‚น2.52 B11.1%
2015 โ‚น2.27 B-1.46%
2014 โ‚น2.30 B-5.8%
2013 โ‚น2.45 B22.25%
2012 โ‚น2.00 B14.65%
2011 โ‚น1.74 B68.81%
2010 โ‚น1.03 B24.11%
2009 โ‚น0.83 B5.16%
2008 โ‚น0.79 B92.18%
2007 โ‚น0.41 B-73.8%
2006 โ‚น1.57 B43.69%
2005 โ‚น1.09 B82.04%
2004 โ‚น0.60 B36.91%
2003 โ‚น0.44 B8.08%
2002 โ‚น0.40 B86.06%
2001 โ‚น0.21 B153.3%
2000 โ‚น86.38 M-14.86%
1999 โ‚น0.10 B-17.71%
1998 โ‚น0.12 B-54.53%
1997 โ‚น0.27 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Boston Scientific
BSX
โ‚น1.994 T 9,204.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚น3.49 B-83.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น130.78 B 510.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA